キーワード、オーダーコード、製品コード、またはシリアル番号で検索してください(例:「CM442」や「技術仕様書」)
2 文字以上を入力して検索を開始してください。

Cell line development meets Raman spectroscopy

KBI Biopharma’s monitoring of a diverse array of cell lines and cell concentrations in minimal volume for automated cell cultivation

With Endress+Hauser's support, KBI Biopharma has developed a robust predictive model using a Raman analyzer system to monitor CHO-M cell cultures. This non-invasive technique, requiring smaller sample volumes than traditional methods, is ideal for cell concentration monitoring in cell line development. KBI Biopharma plans to expand the use of Raman technology for broader upstream processing applications and extended process parameter monitoring of CHO cell cultures.

Benefits:

  • Easy-to-use system: Real-time data acquisition and online process provides valuable process insights with no complex modeling and an intuitive display of results

  • Production cost reduction and sustainability: Minimal analysis reagents and a consumable-free design helps to lower production costs. Cell counting is typically performed to monitor cell growth rates throughout the routine cell passaging process

  • Process automation compatibility: The Raman flow assembly allows for a seamless integration into future automated cell cultivation platforms

Alexandra Martiné, Director, Cell Line Generation & Automation

The expertise and support from the Raman application scientists at Endress+Hauser were instrumental in advancing our innovative cell line development. 

Alexandra Martiné, Director, Cell Line Generation & Automation
KBI Biopharma

Customer challenges

KBI Biopharma focuses on enhancing its process automation at different stages of a research cell bank generation, taking into consideration key criteria: 

  • Low volume: At early cell line development stages, volumes of cultures are within the milliliter range.

  • High-throughput: Hundreds of isolated clone candidates need to be screened to select the right producer.

  • Speed: Reducing timelines in cell line development processes is critical to accelerate the biologic’s development path.

Our solution

KBI Biopharma chose to partner with Endress+Hauser to screen for cell growth performances during CLD using Raman spectroscopy, from the design of the experiments down to chemometrics modeling support and training. The selected Raman system is tailored for small volume and flow paths, leveraging signal amplification and low-noise technology to deliver fast results. It consists of the following components: 

  • Raman Rxn2 analyzer 

  • Rxn-10 probe

  • Raman flow assembly 

  • シンプルな製品

  • 選定、設置、操作が簡単

技術的卓越性

シンプルさ

  • 標準的製品

  • 高い信頼性と堅牢性、容易なメンテナンス

技術的卓越性

シンプルさ

  • ハイエンド製品

  • 高性能で高い利便性

技術的卓越性

シンプルさ

  • 特殊仕様の製品

  • 要件の厳しいアプリケーション向けに設計

技術的卓越性

シンプルさ

高い柔軟性

FLEX セレクション 技術的卓越性 シンプルさ
  • F
  • L
  • E
  • X

Fundamental セレクション

基本的な測定要件に対応

技術的卓越性
シンプルさ
  • F
  • L
  • E
  • X

Lean セレクション

コアプロセスの要件に対応

技術的卓越性
シンプルさ
  • F
  • L
  • E
  • X

Extended セレクション

革新的な技術でプロセスを最適化

技術的卓越性
シンプルさ
  • F
  • L
  • E
  • X

Xpert セレクション

最も困難なアプリケーションにも対応

技術的卓越性
シンプルさ

高い柔軟性